Till Adhikary

2.4k total citations · 1 hit paper
31 papers, 1.9k citations indexed

About

Till Adhikary is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Till Adhikary has authored 31 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 11 papers in Immunology and 5 papers in Oncology. Recurrent topics in Till Adhikary's work include Peroxisome Proliferator-Activated Receptors (13 papers), Immune cells in cancer (6 papers) and Immune Cell Function and Interaction (5 papers). Till Adhikary is often cited by papers focused on Peroxisome Proliferator-Activated Receptors (13 papers), Immune cells in cancer (6 papers) and Immune Cell Function and Interaction (5 papers). Till Adhikary collaborates with scholars based in Germany, United States and Netherlands. Till Adhikary's co-authors include Rolf Müller, Sabine Müller‐Brüsselbach, Florian Finkernagel, Silke Reinartz, Andrea Nist, Thorsten Stiewe, Alexander Visekruna, Uwe Wagner, Maik Luu and Sabine Pautz and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Till Adhikary

30 papers receiving 1.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes

2019 370 citations Maik Luu, Sabine Pautz et al. Nature Communications profile →

Peers

Countries citing papers authored by Till Adhikary

Since Specialization

Citations

This map shows the geographic impact of Till Adhikary's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Till Adhikary with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Till Adhikary more than expected).

Fields of papers citing papers by Till Adhikary

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Till Adhikary. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Till Adhikary. The network helps show where Till Adhikary may publish in the future.

Co-authorship network of co-authors of Till Adhikary

This figure shows the co-authorship network connecting the top 25 collaborators of Till Adhikary. A scholar is included among the top collaborators of Till Adhikary based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Till Adhikary. Till Adhikary is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Haptoglobin buffers lipopolysaccharides to delay activation of NFκB 2024 ·Frontiers in Immunology ·(unknown), (unknown), (unknown), (unknown), (unknown), Stephan Awe, Andrea Nist, Thorsten Stiewe, Oliver Stehling, Sven‐Andreas Freibert, Till Adhikary, Ho‐Ryun Chung	2
2	Pi-seq—A customizable multichannel syringe pump for microfluidics 2024 ·HardwareX ·(unknown), (unknown), Clemens Thölken, Patrick Meyer, (unknown), Ho‐Ryun Chung, Till Adhikary	1
3	Tumor-suppressive disruption of cancer subtype-associated super enhancer circuits by small molecule treatment 2023 ·NAR Cancer ·(unknown), (unknown), Anna Brichkina, Florian Finkernagel, Alexander Visekruna, Andrea Nist, Thorsten Stiewe, Michael Daude, Wibke E. Diederich, Thomas M. Gress, Till Adhikary, Matthias Lauth	2
4	KLF4-mediated upregulation of the NKG2D ligand MICA in acute myeloid leukemia: a novel therapeutic target identified by enChIP 2023 ·Cell Communication and Signaling ·(unknown), Viviane Ponath, (unknown), Till Adhikary, Johannes Graumann, Andreas Neubauer, Elke Pogge von Strandmann	15
5	The mammalian Hedgehog pathway is modulated by ANP32 proteins 2021 ·Biochemical and Biophysical Research Communications ·(unknown), Anna Brichkina, Till Adhikary, Matthias Lauth	5
6	The short-chain fatty acid pentanoate suppresses autoimmunity by modulating the metabolic-epigenetic crosstalk in lymphocytes breakdown → 2019 ·Nature Communications ·Maik Luu, Sabine Pautz, Vanessa Kohl, Rajeev Singh, Rossana Romero, Sébastien Lucas, Jörg Hofmann, Hartmann Raifer, Niyati Vachharajani, Lucia Campos Carrascosa, Boris Lamp, Andrea Nist, Thorsten Stiewe, Yoav D. Shaul, Till Adhikary, Mario M. Zaiss, Matthias Lauth, Ulrich Steinhoff, Alexander Visekruna	370
7	Chromatin Binding of c-REL and p65 Is Not Limiting for Macrophage IL12B Transcription During Immediate Suppression by Ovarian Carcinoma Ascites 2018 ·Frontiers in Immunology ·(unknown), Florian Finkernagel, (unknown), (unknown), Barbara Joos, Andrea Nist, Thorsten Stiewe, Alexander Visekruna, Uwe Wagner, Silke Reinartz, Sabine Müller‐Brüsselbach, Rolf Müller, Till Adhikary	11
8	Regulation of the effector function of CD8+ T cells by gut microbiota-derived metabolite butyrate 2018 ·Scientific Reports ·Maik Luu, (unknown), (unknown), (unknown), Hanna Leister, Sabine Pautz, Till Adhikary, Alexander Visekruna	246
9	Epigenome-wide DNA methylation profiling in Progressive Supranuclear Palsy reveals major changes at DLX1 2018 ·Nature Communications ·Axel Weber, Sigrid C. Schwarz, Jörg Tost, Dietrich Trümbach, Pia Winter, Florence Busato, Paweł Tacik, Anita Windhorst, Maud Fagny, Thomas Arzberger, Catriona McLean, John C. van Swieten, (unknown), Daniela M. Vogt Weisenhorn, Wolfgang Wurst, Till Adhikary, Dennis W. Dickson, Günter U. Höglinger, Ulrich Müller	19
10	The Unique Molecular and Cellular Microenvironment of Ovarian Cancer 2017 ·Frontiers in Oncology ·Thomas Worzfeld, Elke Pogge von Strandmann, Magdalena Huber, Till Adhikary, Uwe Wagner, Silke Reinartz, Rolf Müller	206
11	Interferon signaling in ascites-associated macrophages is linked to a favorable clinical outcome in a subgroup of ovarian carcinoma patients 2017 ·BMC Genomics ·Till Adhikary, Annika Wortmann, Florian Finkernagel, Sonja Lieber, Andrea Nist, Thorsten Stiewe, Uwe Wagner, Sabine Müller‐Brüsselbach, Silke Reinartz, Rolf Müller	47
12	A transcriptome-based global map of signaling pathways in the ovarian cancer microenvironment associated with clinical outcome 2016 ·Genome biology ·Silke Reinartz, Florian Finkernagel, Till Adhikary, (unknown), Tim Schumann, Yvonne Schober, Wolfgang Andreas Nockher, Andrea Nist, Thorsten Stiewe, Julia M. Jansen, Uwe Wagner, Sabine Müller‐Brüsselbach, Rolf Müller	86
13	Lysophosphatidylcholines activate PPARδ and protect human skeletal muscle cells from lipotoxicity 2016 ·Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids ·(unknown), Xinjie Zhao, Till Adhikary, Jia Li, Guowang Xu, Hans‐Ulrich Häring, Erwin Schleicher, Rainer Lehmann, Cora Weigert	38
14	The transcriptional PPARβ/δ network in human macrophages defines a unique agonist-induced activation state 2015 ·Nucleic Acids Research ·Till Adhikary, Annika Wortmann, Tim Schumann, Florian Finkernagel, Sonja Lieber, Katrin Roth, (unknown), Wibke E. Diederich, Andrea Nist, Thorsten Stiewe, (unknown), Silke Reinartz, Sabine Müller‐Brüsselbach, Rolf Müller	66
15	In Vivo Studies of PPAR-Chromatin Interactions: Chromatin Immunoprecipitation for Single-Locus and Genomewide Analyses 2012 ·Methods in molecular biology ·Till Adhikary, Rolf Müller	5
16	Inverse PPARβ/δ agonists suppress oncogenic signaling to the ANGPTL4 gene and inhibit cancer cell invasion 2012 ·Oncogene ·Till Adhikary, Dominique T. Brandt, Kerstin Kaddatz, (unknown), (unknown), Wolfgang Meißner, Florian Finkernagel, (unknown), Sonja Lieber, Maren Scharfe, Michael Jarek, (unknown), (unknown), Wibke E. Diederich, Silke Reinartz, Robert Grosse, Sabine Müller‐Brüsselbach, Rolf Müller	75
17	High-Affinity Peroxisome Proliferator-Activated Receptor β/δ-Specific Ligands with Pure Antagonistic or Inverse Agonistic Properties 2011 ·Molecular Pharmacology ·(unknown), (unknown), Till Adhikary, Kerstin Kaddatz, Veronika F.S. Pape, (unknown), G. Klebe, Sabine Müller‐Brüsselbach, Wibke E. Diederich, Rolf Müller	35
18	Genomewide Analyses Define Different Modes of Transcriptional Regulation by Peroxisome Proliferator-Activated Receptor-β/δ (PPARβ/δ) 2011 ·PLoS ONE ·Till Adhikary, Kerstin Kaddatz, Florian Finkernagel, (unknown), Wolfgang Meißner, Maren Scharfe, Michael Jarek, Helmut Blöcker, Sabine Müller‐Brüsselbach, Rolf Müller	64
19	Transcriptional Profiling Identifies Functional Interactions of TGFβ and PPARβ/δ Signaling 2010 ·Journal of Biological Chemistry ·Kerstin Kaddatz, Till Adhikary, Florian Finkernagel, Wolfgang Meißner, Sabine Müller‐Brüsselbach, Rolf Müller	56
20	Reverse crosstalk of TGFβ and PPARβ/δ signaling identified by transcriptional profiling 2010 ·Nucleic Acids Research ·(unknown), Till Adhikary, Kerstin Kaddatz, Florian Finkernagel, Wolfgang Meißner, Sabine Müller‐Brüsselbach, Rolf Müller	42

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact